Fachliteratur Gastroenterologie: Neoplasien Pankreas

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie

18. April 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 2988


	Artikel 1 - 20 / 59746

	Clinicopathological Features and Prognostic Factors of Gastroenteropancreatic Neuroendocrine Tumors: A Single-Center Experience. Cancer Control Ergenç M, Yaz, Y, Akmercan A, Bulut A, Karpuz , Co, Bozkurtlar E, Uprak TK, At, U, Cingi A, Günal Ö, Ye. PMID: 41998800 [PubMed - indexed for MEDLINE]
	Neoadjuvant or conversion therapy nullifies the prognostic impact of surgical margin width in hepatocellular carcinoma: a single-center retrospective study. BMC Surg Xie H, Liao Y, Liang T, Huang H, Wei Y, Yang K, Qin C, Chen M, Song J, Zhou X, Zhou Y, Yang C, Liao X, Su H, Zhu G, Peng M, Han C, Peng's T. PMID: 41998639 [PubMed - as supplied by publisher]
	Author Correction: PanMETAI - a high performance tabular foundation model for accurate pancreatic cancer diagnosis via NMR metabolomics. Nat Commun Wu DN, Jen J, Fajiculay E, Hsu MF, Chang MC, Yeh JC, Sargsyan K, Kupcinskas J, Skieceviciene J, Steponaitiene R, Morkunas E, Gedgaudiene G, Hsu CP, Chang YT, Hu CM. PMID: 41997919 [PubMed - in process]
	A community-hospital collaborative diagnostic pathway for earlier detection of pancreatic cancer: Long-term impact of the Onomichi Method. Pancreatology Hanada K, Shimizu A, Tanaka S, Sasaki N. PMID: 41997755 [PubMed - as supplied by publisher]
	The impact of MRI on real-world staging pathways and management timelines in pancreatic cancer: A systematic review. Eur J Surg Oncol Memon M, Chatzielefthreiou E, Kowal MR, Shapey I, Albazaz R, Smith A, Pathak S. PMID: 41996777 [PubMed - as supplied by publisher]
	Global, regional, and national analyses of the burden of pancreatic cancer attributable to high fasting plasma glucose from 1990 to 2021: A longitudinal observational study. Medicine (Baltimore) Han J, Liang Q, Lv Y, Chen H, Lei X, Liao C, Yang S, Chu F. PMID: 41995512 [PubMed - indexed for MEDLINE]
	Impact of diabetes mellitus on treatment efficacy in patients with advanced pancreatic cancer: the Italian, multicenter, observational PANCAKE study. ESMO Gastrointest Oncol Andena P, Tine G, Nichetti F, Pretta A, Bartalini L, Ljevar S, Michelotti A, Salvatore L, Prisciandaro M, Franza A, Grelli G, Ziranu P, Bensi M, Mazzaferro V, Coppa J, Sciortino C, Zapelloni G, Pircher C, Garattini SK, Vivaldi C, Tortora G, Scartozzi M, de Braud F, Pietrantonio F, Miceli R, Niger M. PMID: 41994033 [PubMed]
	Comprehensive review of current management and precision medicine in pancreatic cancer. J Chin Med Assoc Yu HY, Lin LG, Chao Y, Li CP. PMID: 41992406 [PubMed - indexed for MEDLINE]
	Usefulness of an S-1 dosage formula for predicting adverse events in adjuvant chemotherapy for curatively resected pancreatic cancer: an exploratory analysis of the randomized clinical trial (JASPAC-01). J Gastroenterol Ishigaki K, Nakai Y, Kashiwabara K, Fujishiro M, Gotohda N, Toyama H, Maeda A, Shimizu Y, Miyamoto A, Takahashi A, Morinaga S, Yanagibashi H, Goto T, Sakuma Y, Tomikawa M, Ojima H, Okamura Y, Fukutomi A, Boku N, Uesaka K. PMID: 41991754 [PubMed - as supplied by publisher]
	Glucagon-like Peptide-1 receptor agonists are not associated with increased risk of pancreatic cancer: A systematic review and meta-analysis. Pancreatology Lauri G, Arcidiacono PG, Facciorusso A, Capurso G, Tacelli M. PMID: 41991368 [PubMed - as supplied by publisher]
	Preclinical and First-in-Human Study of Carbonic Anhydrase IX-Targeting Theranostic Pair, [(68)Ga]Ga/[(177)Lu]Lu-NYM096, in Clear Cell Renal Cell Carcinoma. J Nucl Med Wang J, Yan X, Liu M, Yang X, Zheng G, Li X, Cheng Y, Bai C, Zhang Y, Zhu W, Huo L. PMID: 41991341 [PubMed - as supplied by publisher]
	Pre-diagnostic prescription patterns in pancreatic cancer: a retrospective cohort study. Br J Gen Pract Morel CH, Walter FM, Virpal P, Arendse KD, Funston G. PMID: 41991223 [PubMed - as supplied by publisher]
	PCO26-278: Genetically Determined Circulating Metabolites and Pancreatic Cancer Risk: Causal Insights From a Systematic Review of Mendelian Randomization Studies. J Natl Compr Canc Netw Bodrova E, Pasnoor DS, Dash S, Gupta M, Patel K, Ahmed MN, Reddy SA, Asfeen U, Jain A, Desai R. PMID: 41991061 [PubMed - in process]
	Maternal obesity and the intergenerational risk of cancer: Epidemiologic evidence and mechanistic insights. Cancer Epidemiol Moeckli B, Rocha M, Wassmer CH, El Hajji S, Collet TH, Lacotte S, Toso C. PMID: 41990710 [PubMed - as supplied by publisher]
	Increasing Use of Germline Genetic Testing in Pancreatic Ductal Adenocarcinoma and Relationship to Clinical Outcome: A Single-Institution Study. JCO Precis Oncol O'Connor TN, Schultz E, Horowitz M, Alexander MH, Fountzilas C, Cherkassky L, Onel K, Knudsen ES, Witkiewicz AK. PMID: 41990298 [PubMed - indexed for MEDLINE]
	The central regulator HIF-1Î± in digestive system pathologies: inflammation and cancer. Front Immunol Gou G, Wen M, Li G, Shu F, Wang F, Liu Y, Xie R, Xu J. PMID: 41988193 [PubMed - indexed for MEDLINE]
	Prognostic and diagnostic significance of serum p53 antibody levels in patients with surgically treated pancreatic cancer. Oncol Lett Okada R, Otsuka Y, Kajiwara Y, Matsumoto Y, Ito Y, Shimada H. PMID: 41987866 [PubMed]
	Granulomatosis with Polyangiitis (Wegener Granulomatosis) Presenting as a Pancreatic Mass: A Rare Malignancy Mimic. Am J Case Rep Sain S, Das S, Bhargava V, Jain S, Nundy S. PMID: 41987408 [PubMed - indexed for MEDLINE]
	Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial. Nat Commun Huff AL, Haldar SD, Girgis AA, Wang HH, Danilova L, Heumann T, Berg M, Wang Y, Andaloori L, Hernandez A, Longway G, Barrett B, Zhu Z, Davis-Marcisak E, Thoburn C, Leatherman J, Mitchell S, Lee JW, Shu DH, Konig MF, Mog BJ, Montagne J, Coyne EM, Bever K, Baretti M, Yarchoan M, Anders RA, Kagohara LT, Laheru D, Thomas AM, Durham J, Nauroth JM, Lu J, Wang H, Fertig EJ, Ho WJ, Azad NS, Jaffee EM, Zaidi N. PMID: 41986375 [PubMed - in process]
	Convergence of multiplexed immunosensors, nanotechnology, and AI for early pancreatic cancer diagnosis. Clin Chim Acta Abuhassan Q, Mutee AF, Shareef A, Pate PN, Jyothi SR, Singh G, Maharana L, Arora V, Polatova D, Sameer HN, Yaseen A, Athab ZH, Adil M. PMID: 41985833 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 59746

Seite 1 von 2988



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung